Social determinants of health in studies using PROMs to assess toxicities associated with immune checkpoint inhibitor treatment: a systematic review

Collection and consideration of SDOH in studies using PROMs to assess toxicities in ICI treatment in cancer care are limited. Reported SDOH are not sufficient as they overlook important characteristics such as religion, disability, and sexual orientation. Improved accuracy and details are essential in understanding the needs of various populations. Availability of these data will facilitate understanding of health inequalities and prompt action to address avoidable disparities in health, improving outcomes for all.